Advertisement

Esophageal dysphagia - Biotech, Pharma and Life Science Channel

21:12 EDT 19th May 2013 | BioPortfolio

PubMed Articles [ 1523 Associated PubMed Articles listed on BioPortfolio]

Treatment for hepatitis C virus-induced portal hypertension in leukemic children.

Children with acute leukemia are at high risk of hepatitis C infection, either by immunosuppression secondary to chemotherapy or by multiple transfusions of blood products during the course of the dis...

Boerhaave's syndrome during bowel preparation with polyethylene glycol in a patient with postpolypectomy bleeding.

Boerhaave's syndrome is spontaneous rupture of the esophagus, a rare condition with high mortality that occurs most often after forceful vomiting. Polyethylene glycol (PEG) solution is the most common...

Biodegradable stent for the treatment of a colonic stricture in Crohn's disease.

Biodegradable polydioxanone stents were developed for the treatment of refractory benign esophageal strictures but have been suggested as a new therapeutic option for intestinal strictures. The primar...

Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.

Esophageal cancer is among the leading causes of cancer-related deaths worldwide. The management of patients with esophageal cancer is determined to a large extent by patient performance status, locat...

Age-related Differences in Tongue-Palate Pressures for Strength and Swallowing Tasks.

The tongue plays a key role in the generation of pressures for transporting liquids and foods through the mouth in swallowing. Recent studies suggest that there is an age-related decline in tongue str...

miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.

We report the emerging role of microRNA (miRNA) deregulation associated with activation of an oncogene SOX4 (a member of the SRY-related HMG-box) in esophageal carcinoma. Paired esophageal cancer and...

Treatment options for esophageal squamous cell carcinoma.

Introduction: The treatment for esophageal squamous cell carcinoma (SCC) depends on its etiology. For mucosal cancer, endoscopic resection is standard; while for locally advanced cancer, esophagectomy...

Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients.

PURPOSE: The aim of this study was to identify perioperative risk factors that are associated with postoperative atrial fibrillation (AF) and the outcomes of different pharmacological interventions in...

Erratum to: BMP7 Expression in Esophageal Squamous Cell Carcinoma and Its Potential Role in Modulating Metastasis.

Discrepancies and pitfalls in diagnosis and therapy of esophageal columnar metaplasia/Barrett's esophagus: A personal view.

News Articles [ 267 Associated News Articles listed on BioPortfolio]

hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer

The National Cancer Institute reports that obese people are twice as likely to develop esophageal cancer. Diet Doc's newly improved and modernized version of hCG diet plans makes losing weight saf...

hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer

Mobile, AL (PRWEB) May 18, 2013 Although obesity is associated with an increased risk for several malignant tumors, the association between obesity and esophageal adenocarcinoma, a type of esophage...

NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLEâ„¢ Imaging System

NinePoint Medical, Inc., an emerging leader in the development of medical devices for advanced optical imaging, today announced the commercial launch of its proprietary Nvi...

New Study: Oral Sex Linked to Throat Cancer; polyDNA Recommends Gene-Eden-VIR against HPV, the Virus Associated with Throat Cancer

92.6% of patients with throat cancer also had an HPV infection, according to a new paper published in April, 2013 from the American Journal of Gastroenterology. (1) polyDNA suggests taking Gene-Eden-V...

NinePoint Medical to Present NvisionVLE Clinical Data at Digestive Disease Week 2013

NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, today announced that new clinical data on its proprietary NvisionVLEâ...

Acute Variceal Bleeding: Ligation and Vasoconstrictor vs PPI

This new study compares 2 different treatment options for acute esophageal variceal bleeding. Does ligation and vasoconstriction work better than PPIs? Journal of Gastroenterology and Hepatology

First Volumetric OCT Device Cleared in the US for Endoscopic, Esophageal Imaging

For the first time, an optical coherence tomography imaging system will enable both physicians and pathologists to visualize real-time,...

Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma

Dongxin Lin and colleagues report a genome-wide association study identifying common variants in SLC39A6 associated with length of survival in individuals with esophageal squamous-cell carcinoma (ESCC...

NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE

NinePoint Medical Inc., an emerging leader in the development of medical devices for in vivo imaging, announced that it has received an additional 510(k) clearance from the U.S. Food and Drug Administ...

C2 Therapeutics’ Announces 15th Patient Enrollment in its Cryoballoon Focal Ablation System Clinical Trial for Patients with Barrett’s Esophagus

Investigators Cite Device Ease of Use and Speed of Procedure as Potential Advantages C2 Therapeutics, a privately held company founded to address the limitations of cur...

Events [0 Results]

None

Companies [ 8 Associated Companies listed on BioPortfolio]

Cascade Technologies Corp.

Cascade Technologies Corp., through its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI), is a development-stage medical imaging device company, applying its proprie...

Cascade Technologies Corporation

Cascade Technologies Corp., through its wholly owned subsidiary Spectral Molecular Imaging, Inc., is a development-stage, medical imaging device company, applying its proprietary...

DEBRA

Epidermolysis Bullosa (EB) is a rare genetic disorder characterized by the presence of extremely fragile skin and recurrent blister formation, resulting from minor mechanical fric...

Phagenesis Ltd

Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient’s ability to swallow is damaged....

Spectral Molecular Imaging, Inc.

Spectral Molecular Imaging, Inc., a wholly-owned subsidiary of Cascade Technologies, Inc., is a development-stage, medical imaging device company, applying its proprietary hypersp...

Phagenesis

Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient’s ability to swallow is damaged....

Swallow Solutions, LLC

Swallow Solutions, LLC is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. We focus on two areas related to dysphagia – therapeutic...

C2 Therapeutics

C2 Therapeutics was founded in 2007 to address the limitations of current Barrett’s Esophagus treatment options. Headquartered in Redwood City, California, C2 is a privately...

Clinical Trials [ 429 Associated Clinical Trials listed on BioPortfolio]

Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)

Helicobacter pylori (Hp) is a major cause of chronic-active gastritis and primary duodenal ulcers, and is strongly linked to gastric cancer. Most Hp infections worldwide are acquired in c...

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

Surgery has been the standard of care for esophageal cancer for many years, with limited success. At present, several studies are underway nationwide which utilize chemotherapy combined w...

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

In this project, we are trying to identify patients with the earliest signs of abnormality in the lining of the lower part of the food pipe (or esophagus) known as intestinal metaplasia (I...

Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer

The primary objectives of this study are to assess the feasibility (completion of full treatment) in both arms and to assess endoscopic complete response rate in both arms. The secondary...

Selective Dose Escalation for Esophageal Cancer

This prospective study was designed to assess the outcomes (survival and failure patterns) of therapy for localized esophageal cancer with conventional dose radiation (RT; 50.4 Gy) with co...

A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab

Eosinophilic esophagitis (EE) is an increasingly recognized condition characterized by dysphagia, food impaction or other obstructive esophageal symptoms in children and young adults....

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help ki...

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

RATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in dif...

Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well gefitinib works in treati...

FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer

RATIONALE: Drugs used in chemotherapy, such as FR901228 and flavopiridol, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from div...

Medical and Biotech [MESH] Definitions

Muscular Dystrophy, Oculopharyngeal

An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.

Diverticulosis, Esophageal

A pathological condition characterized by the presence of a number of ESOPHAGEAL DIVERTICULA in the ESOPHAGUS.

Lingual Goiter

Pathological enlargement of the LINGUAL THYROID, ectopic thyroid tissue at the base of the TONGUE. It may cause upper AIRWAY OBSTRUCTION; DYSPHAGIA; or HYPOTHYROIDISM symptoms.

Esophageal Sphincter, Lower

The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. (Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415)

Esophageal Sphincter, Upper

The structure at the pharyngoesophageal junction consisting chiefly of the CRICOPHARYNGEUS MUSCLE. It normally occludes the lumen of the ESOPHAGUS, except during SWALLOWING.

Search BioPortfolio:
Advertisement
review and buy Esophageal dysphagia market research data and corporate reports here

Channels Quicklinks

Advertisement